Genpharmasec

Genpharmasec Book Value per Share

The Book Value per Share of Genpharmasec (531592.BO) as of Oct 31, 2026 is 1.18 INR. In the previous year, Book Value per Share was 1.16 INR — a change of 1.19% (higher).

Book Value per Share

1.18INR

YoY

1.19%

Last updated:

Book Value per Share of Genpharmasec is 2025 1.18 INR. Book Value per Share of Genpharmasec was 2024 1.16 INR. It decreases by 1.19% higher compared to the previous year.

The Genpharmasec Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
-0.02 INR
Jan 1, 2019
0.39 INR
Jan 1, 2020
0.34 INR
Jan 1, 2021
0.37 INR
Jan 1, 2022
0.28 INR
Jan 1, 2023
0.28 INR
Jan 1, 2024
1.16 INR
Jan 1, 2025
1.18 INR
The Genpharmasec Book Value per Share history
YEARBook Value per ShareYoY
1.18INR+1.19%
1.16INR+320.05%
0.28INR-0.26%
0.28INR-25.61%
0.37INR+8.55%
0.34INR-11.92%
0.39INR-2,602.86%
-0.02INR-5.00%
-0.02INR-1.66%
-0.02INR-9.67%
-0.02INR-2.07%
-0.02INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genpharmasec Stock analysis

What does Genpharmasec do? Genpharmasec Ltd. generates revenue through the manufacturing and trading of organic and inorganic chemicals, dyes, and pigments, with key products including potassium hydroxide and caustic soda. The company operates in two main segments: the distribution of diagnostic equipment and investment and trading in securities. Its primary customers are businesses requiring chemical products for industrial applications, while the diagnostic equipment segment serves healthcare providers needing medical devices. The securities trading segment targets institutional investors seeking financial market participation. The company's chemical products are sold to industrial clients across various sectors, leveraging its manufacturing capabilities for potassium hydroxide and caustic soda. Diagnostic equipment distribution caters to healthcare institutions requiring specialized medical tools, while securities trading involves active market participation for financial gains. These segments collectively drive the company's revenue streams without relying on external partnerships or third-party services. Revenue is derived from direct sales of chemical products, distribution of diagnostic equipment, and trading activities in securities. The firm's operational focus remains on chemical manufacturing and trading, diagnostic equipment distribution, and securities investment, with no mention of additional revenue sources or external dependencies in its business description. Genpharmasec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genpharmasec stock

Book Value per Share of Genpharmasec is 1.18 INR in 2025.

Book Value per Share of Genpharmasec changed from 1.16 INR to 1.18 INR, representing a 1.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Genpharmasec since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Genpharmasec

All Key Metrics — Genpharmasec